SOURCE: Fermentalg


October 28, 2014 04:51 ET

Agnes Paillard Is Co-Opted as an Independent Member of Fermentalg's Board of Directors

LIBOURNE, FRANCE--(Marketwired - Oct 28, 2014) - Fermentalg (EURONEXT PARIS: FALG), an industrial biotechnology company that specializes in the production of oils and proteins derived from microalgae, is pleased to announce that Mrs Agnès Paillard has been co-opted as an independent director1.

Agnès Paillard is the current Chairman of the Board of Directors of the French National Institute for Industrial Property (Inpi), President of the Aerospace Valley competitiveness cluster and Vice-President responsible for regional innovation policy for Airbus Group France. A graduate of ESPCI ParisTech, Agnès Paillard was Chief Executive of Serma Technologies from 1995 to 2002 before being appointed Deputy Director in charge of economic development, research and technology transfer for the Regional Council of Aquitaine until 2009.

For Pierre Calleja, Founder and Chairman and CEO of Fermentalg: "We are immensely proud to welcome an independent director of Agnès Paillard's caliber and precious expertise. I would also like to take this opportunity to thank Sofiprotéol representative Claire Maingon for her work as a member of the Board of Directors over the past 2 years, and once again pay homage to Professor Daniel Thomas who was a director for Fermentalg from 2011 and who sadly passed away last May. The day of tribute organized by the Enzyme and Cellular Engineering laboratory of the Université de Technologie de Compiègne on 10 October once again brought to light the Professor's extensive contribution to the field of life sciences and biotechnologies."

Following this co-opting, Fermentalg's Board of Directors shall include:

  • Pierre Calleja, Chairman
  • Bernard Maitre, representative for Emertec Gestion
  • Agnès Paillard, independent director
  • Gilles Schang, representative for Bpifrance Investissement
  • Stéphane Villecroze, representative for Demeter Partners

Fermentalg's decision to appoint a new independent director to its Board is part of its commitment to implementing the procedures needed to ensure its compliance with the core recommendations of MiddleNext's corporate governance code.

About Fermentalg

Founded in 2009 by Pierre Calleja, Fermentalg is an industrial biotechnology company that specializes in producing sustainable oils and proteins derived from the exceptional properties of microalgae. Its patented technology allows it to target a range of fast-growing global markets, from nutrition and animal feed to cosmetics and health, green chemistry and energy. Fermentalg has already signed its 1st industrial and commercial joint-venture for the production of Omega-3 oils rich in EPA and DHA as well as several other partnerships with leading industrial groups. Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG). For more information, visit the Fermentalg website at:

1 The resolution to co-opt Mrs Paillard will be ratified by Fermentalg's next Annual General Meeting of shareholders.

Contact Information

  • Press Relations:
    Investor Relations:

    Pierre Calleja
    Chairman and CEO
    Tel: +33 (0)5 57 25 02 20
    Email Contact

    Paul Michalet
    Chief Finance, Strategy & Business Officer
    Tel: +33 (0)5 57 25 79 76
    Email Contact

    ACTUS finance & communication
    Alexandra Prisa
    Tel: +33 (0)1 53 67 35 79
    Email Contact

    ACTUS finance & communication
    Jerome Fabreguettes-Leib
    Tel: +33 (0)1 77 35 04 36
    Email Contact